GlaxoSmithKline (GSK) has received FDA approval for Votrient (pazopanib) for the treatment of patients with advanced soft tissue sarcoma (STS) who have received prior chemotherapy. The approval is based on the results of the randomized, ...
Tags: advanced soft tissue sarcoma, STS, soft tissue sarcomas, GlaxoSmithKline
CytRx Corporation has received a patent covering for its tumour-targeting linker platform technology and pharmaceutical compositions from the European Patent Office (EPO). The company also revealed aldoxorubucin as the new generic ...
Tags: Patent, pharmaceutical technology, pharmaceutical product